Phoenix NP announced an expansion of its service availability across Arizona to help more women access FDA-approved GLP-1 weight loss medications through compliant, manufacturer-direct pharmacies. The ...
Jaguar’s requesting advice from EMA on EU approval pathway for general diarrhea of FDA conditionally approved Canalevia® A ...
ESTERO, FLORIDA / ACCESS Newswire / December 2, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) (“Aspire” or the “Company”), a developer of a multi-faceted patent-pending drug delivery technology ...
The U.S. government says a preventative drug is effective in treating New World screwworm infestations in cats, particularly ...
7hOpinion
Anavex Life Sciences: Negative CHMP Decision Does Not Bode Well For Future Approval For Alzheimer's
Anavex Life Sciences' Phase 2B/3 trial failed to achieve statistical significance on both primary endpoints. Read why I ...
A major breakthrough in the treatment of an aggressive form of leukemia is bringing new hope to patients and it started in ...
A once-beleaguered gene-therapy stock just landed a major vote of confidence—and the timing seems anything but accidental.
Weeks after being named head of CDER, Pazdur has submitted paperwork to step down at the end of the month, exacerbating ...
Vorasidenib significantly reduced tumor growth rates in IDH1/2-mutant grade 2 glioma, improving PFS and TTNI compared to ...
FDA moves reshaping drug policy include fast-track programs, updated biosimilar guidance, and new rare disease approval pathways.
Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s albuterol sulfate inhalation aerosol ...
Shares of several major vaccine makers lost ground Monday following a report U.S. vaccine approval rules could become ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback